# A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

> **NCT06577935** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Angitia Biopharmaceuticals** · enrollment: 379 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** AGA2118
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06577935
- **Lead sponsor:** Angitia Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2026-12
- **Final completion:** 2028-03
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06577935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06577935, "A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06577935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*